LV11954A - 14-alfa,17-alfa-C2-tiltina saites 19-nor-progesterona atvasinajumi - Google Patents

14-alfa,17-alfa-C2-tiltina saites 19-nor-progesterona atvasinajumi

Info

Publication number
LV11954A
LV11954A LV970125A LV970125A LV11954A LV 11954 A LV11954 A LV 11954A LV 970125 A LV970125 A LV 970125A LV 970125 A LV970125 A LV 970125A LV 11954 A LV11954 A LV 11954A
Authority
LV
Latvia
Prior art keywords
alpha
bridge
linkages
progesterone derivatives
progesterone
Prior art date
Application number
LV970125A
Other languages
English (en)
Other versions
LV11954B (lv
Inventor
Klaus Schoellkopf
Wolfgang Halfbrodt
Joachim Kuhnke
Wolfgang Schwede
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Hans-Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of LV11954A publication Critical patent/LV11954A/lv
Publication of LV11954B publication Critical patent/LV11954B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LVP-97-125A 1994-12-23 1997-06-20 14-alfa,17-alfa-c2-tiltiņa saites 19-nor-progesterona atvasinājumi LV11954B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide
PCT/EP1995/005107 WO1996020209A2 (de) 1994-12-23 1995-12-23 14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE

Publications (2)

Publication Number Publication Date
LV11954A true LV11954A (lv) 1998-01-20
LV11954B LV11954B (lv) 1998-06-20

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-125A LV11954B (lv) 1994-12-23 1997-06-20 14-alfa,17-alfa-c2-tiltiņa saites 19-nor-progesterona atvasinājumi

Country Status (33)

Country Link
US (3) US5827842A (lv)
EP (1) EP0799238B1 (lv)
JP (1) JPH10511379A (lv)
KR (1) KR100400621B1 (lv)
CN (1) CN1109689C (lv)
AR (1) AR002263A1 (lv)
AT (1) ATE193300T1 (lv)
AU (1) AU692346B2 (lv)
BG (1) BG63274B1 (lv)
CA (1) CA2208605C (lv)
CZ (1) CZ292696B6 (lv)
DE (2) DE4447401A1 (lv)
DK (1) DK0799238T3 (lv)
EE (1) EE03356B1 (lv)
ES (1) ES2151612T3 (lv)
FI (1) FI972624A (lv)
GR (1) GR3034261T3 (lv)
HU (1) HUP0600457A2 (lv)
IL (1) IL116504A (lv)
LT (1) LT4295B (lv)
LV (1) LV11954B (lv)
NO (1) NO310198B1 (lv)
NZ (1) NZ298770A (lv)
PL (1) PL182642B1 (lv)
PT (1) PT799238E (lv)
RO (1) RO119366B1 (lv)
RU (1) RU2169153C2 (lv)
SI (1) SI9520137A (lv)
SK (1) SK282281B6 (lv)
TW (1) TW333536B (lv)
UA (1) UA45382C2 (lv)
WO (1) WO1996020209A2 (lv)
ZA (1) ZA9510923B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503919B1 (ko) * 1996-09-03 2005-07-27 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 비타민 디 및 스테로이드 유도체들의 합성에 사용되는 중간체들의 제조방법
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
US6147065A (en) 2000-11-14
DE59508403D1 (de) 2000-06-29
EP0799238A2 (de) 1997-10-08
BG63274B1 (bg) 2001-08-31
AU4433896A (en) 1996-07-19
LT4295B (lt) 1998-02-25
UA45382C2 (uk) 2002-04-15
CA2208605C (en) 2008-07-15
CA2208605A1 (en) 1996-07-04
ATE193300T1 (de) 2000-06-15
DE4447401A1 (de) 1996-07-04
RO119366B1 (ro) 2004-08-30
ZA9510923B (en) 1996-07-04
MX9704774A (es) 1997-10-31
JPH10511379A (ja) 1998-11-04
FI972624A0 (fi) 1997-06-18
LT97106A (en) 1997-10-27
SK78897A3 (en) 1997-12-10
KR100400621B1 (ko) 2004-02-05
US5973172A (en) 1999-10-26
BG101554A (en) 1998-09-30
NZ298770A (en) 1999-10-28
CN1171115A (zh) 1998-01-21
IL116504A (en) 2001-11-25
PT799238E (pt) 2000-11-30
IL116504A0 (en) 1996-03-31
EP0799238B1 (de) 2000-05-24
US5827842A (en) 1998-10-27
AR002263A1 (es) 1998-03-11
DK0799238T3 (da) 2000-10-09
WO1996020209A2 (de) 1996-07-04
GR3034261T3 (en) 2000-12-29
NO972927L (no) 1997-08-22
LV11954B (lv) 1998-06-20
WO1996020209A3 (de) 1996-09-06
HUP0600457A2 (en) 2006-08-28
PL182642B1 (pl) 2002-02-28
AU692346B2 (en) 1998-06-04
PL320799A1 (en) 1997-10-27
CZ195497A3 (cs) 1998-03-18
NO310198B1 (no) 2001-06-05
ES2151612T3 (es) 2001-01-01
FI972624A (fi) 1997-06-18
CN1109689C (zh) 2003-05-28
TW333536B (en) 1998-06-11
SK282281B6 (sk) 2002-01-07
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
NO972927D0 (no) 1997-06-23
CZ292696B6 (cs) 2003-11-12
EE03356B1 (et) 2001-02-15

Similar Documents

Publication Publication Date Title
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
NL300214I2 (nl) Chinazolinederivaten.
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
BR9700688A (pt) 2-oxo- e 2-tio-1,2-dihidroquinolinil-oxazolidinonas
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
TR199600883A2 (tr) Pürin-6-on türevleri.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
TR199600715A2 (tr) Kefalosforin türevleri.
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
TR199901380A3 (tr) Di-ya da triazo-spiro[4,5] dekan türevleri
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
LV11954A (lv) 14-alfa,17-alfa-C2-tiltina saites 19-nor-progesterona atvasinajumi
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
TR28915A (tr) Naftokinon türevleri.
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
ES1032571Y (es) Gafa,
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FI945785A0 (fi) Pimpelspoe, fiskeredokap
FIU940180U0 (fi) Baotstege, kaerra, landgaong
TR199700927A3 (tr) N-Benzilazolyum türevleri.
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor